Qinghai Spring Medicinal Resources Technology (600381.SH) announces a preliminary estimate of a net loss of 145 million to 174 million yuan for the year 2024.

16/01/2025

GMT Eight

Qinghai Spring Medicinal Resources Technology (600381.SH) announces its performance forecast for 2024, with an estimated net loss attributable to shareholders of the listed company of 145 million to 174 million RMB, and a net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses of 117 million to 146 million RMB.

BAOZUN-W(09991) spent $131,400 to repurchase 138,800 shares on January 15th.

Jiangsu Bojun Industrial Technology (300926.SZ) forecasts a profit increase, with an estimated net profit for the year 2024 of 5.86 billion to 6.79 billion yuan, a growth of 90% to 120%.

Contact: contact@gmteight.com

Qinghai Spring Medicinal Resources Technology (600381.SH) announces a preliminary estimate of a net loss of 145 million to 174 million yuan for the year 2024.

RECOMMEND

US Stock Market Move | Mineralys Therapeutics (MLYS.US) surges over 53% with the positive results of the release of hypertension drug research.

US Stock Market Move | Bitcoin fell below the $80,000 threshold and concept stocks plummeted across the board.

US Stock Market Move | In February, the combined revenue decreased by 11.3% month-on-month. Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) dropped more than 4%.